- Home
- QRVO vs ASND Comparison
QRVO vs ASND Comparison
Compare QRVO & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRVO
- ASND
- Stock Information
- Founded
- QRVO 1957
- ASND 2006
- Country
- QRVO United States
- ASND Denmark
- Employees
- QRVO N/A
- ASND N/A
- Industry
- QRVO Semiconductors
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- QRVO Technology
- ASND Health Care
- Exchange
- QRVO Nasdaq
- ASND Nasdaq
- Market Cap
- QRVO 7.1B
- ASND 7.7B
- IPO Year
- QRVO 1997
- ASND 2015
- Fundamental
- Price
- QRVO $76.07
- ASND $152.43
- Analyst Decision
- QRVO Hold
- ASND Strong Buy
- Analyst Count
- QRVO 19
- ASND 14
- Target Price
- QRVO $91.65
- ASND $197.36
- AVG Volume (30 Days)
- QRVO 2.6M
- ASND 531.7K
- Earning Date
- QRVO 01-28-2025
- ASND 02-12-2025
- Dividend Yield
- QRVO N/A
- ASND N/A
- EPS Growth
- QRVO N/A
- ASND N/A
- EPS
- QRVO 0.28
- ASND N/A
- Revenue
- QRVO $3,790,485,000.00
- ASND $376,478,932.00
- Revenue This Year
- QRVO $0.09
- ASND $47.51
- Revenue Next Year
- QRVO N/A
- ASND $88.30
- P/E Ratio
- QRVO $269.04
- ASND N/A
- Revenue Growth
- QRVO 9.51
- ASND 36.34
- 52 Week Low
- QRVO $64.54
- ASND $111.09
- 52 Week High
- QRVO $130.99
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- QRVO 43.10
- ASND 66.26
- Support Level
- QRVO $76.04
- ASND $118.03
- Resistance Level
- QRVO $80.17
- ASND $157.37
- Average True Range (ATR)
- QRVO 2.43
- ASND 6.50
- MACD
- QRVO -0.73
- ASND 3.62
- Stochastic Oscillator
- QRVO 9.69
- ASND 87.44
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.